title: Assessment of antibiotic prescribing at different hospitals and primary health care facilities.
abstract: In this study, it was aimed to investigate the utilization of antibiotics at various health care facilities. Photocopies of 1250 prescriptions which were containing antibiotics and written out in primary health care facilities (PHCFs), public hospitals (PHs), private hospitals and university hospitals in 10 provinces across Turkey, were evaluated by some drug use indicators. The number of drugs per prescription was 3.23 ± 0.92 and it was highest in PHCFs (3.34 ± 0.84), (p < 0.05). The cost per prescription was 33.3 $, being highest in PHs while being lowest in PHCFs (38.6 $ and 28.2 $ respectively). Antibiotic cost per prescription was 16.7 $ and it was also highest and lowest in PHs and PHCFs respectively (p < 0.05). The most commonly prescribed group of antibiotics was "beta-lactam antibacterials, penicillins" (29.2%) while amoxicillin/clavulanic acid was the most commonly prescribed antibiotic (18.1%). Sixty-one percent of the antibiotics prescribed for acute infections was generics; among facilities being highest in PHCFs (66.5%) and among diagnosis being highest in acute pharyngitis. In general, the duration of antibiotic therapy was approximately 7 days for acute infections. Although much more drugs were prescribed in PHCFs than others, it was found to be in an inverse proportion with both the total cost of prescriptions and the cost of antibiotics. Broad-spectrum antibiotics, beta-lactamase combinations in particular, were considered to be more preferable in all health care facilities is also notable. These results do serve as a guide to achieve the rational use of antibiotics on the basis of health care facilities and indications.
authors: Turkish Ministry of Health, RSHCP, School of Public Health, Ankara, Turkey.
authors: Salih
authors: S
authors: Mollahaliloglu
authors: Ali
authors: A
authors: Alkan
authors: Basak
authors: B
authors: Donertas
authors: Senay
authors: S
authors: Ozgulcu
authors: Ahmet
authors: A
authors: Akici
keywords: Antibiotics; Generic; Health care; Prescribing; Rational use of medicine
references: Croat Med J. 2010 Dec;51(6):524-33
references: 21162165
references: J Antimicrob Chemother. 2006 Jul;58(1):159-67
references: 16698845
references: Int J Antimicrob Agents. 2005 Dec;26 Suppl 3:S170-5
references: 16543079
references: Indian J Med Microbiol. 2011 Apr-Jun;29(2):124-9
references: 21654105
references: J Antimicrob Chemother. 2008 May;61(5):1169-71
references: 18272511
references: Eur J Clin Pharmacol. 2004 May;60(3):211-6
references: 15054566
references: Int J Antimicrob Agents. 2004 May;23(5):446-50
references: 15120721
references: BMC Health Serv Res. 2011 Jan 26;11:17
references: 21269426
references: Eur J Clin Microbiol Infect Dis. 2009 Aug;28(8):893-7
references: 19229561
references: J Infect. 2006 Jan;52(1):9-14
references: 16181680
references: J Clin Epidemiol. 1998 Jan;51(1):61-8
references: 9467635
references: J Antimicrob Chemother. 2008 Aug;62(2):410-5
references: 18400805
references: J Antimicrob Chemother. 2002 Dec;50(6):989-97
references: 12461022
references: J Antimicrob Chemother. 1998 Feb;41(2):259-66
references: 9533469
references: Nagoya J Med Sci. 2011 Aug;73(3-4):157-68
references: 21928697
references: Scand J Infect Dis. 1999;31(2):191-5
references: 10447331
references: Eur J Clin Pharmacol. 2004 Mar;60(1):23-8
references: 14689127
references: J Clin Epidemiol. 1997 Nov;50(11):1297-304
references: 9393386
references: J Clin Pharm Ther. 2009 Oct;34(5):547-54
references: 19744010
references: Pediatr Infect Dis J. 2001 Aug;20(8):751-8
references: 11734736
references: Scand J Infect Dis. 2002;34(6):442-8
references: 12160172
references: JAMA. 2012 Feb 15;307(7):685-92
references: 22337680
references: Expert Rev Pharmacoecon Outcomes Res. 2010 Dec;10(6):707-22
references: 21155704
references: Pac Health Dialog. 2010 Sep;16(2):109-11
references: 21714347
references: J Infect. 2000 Jul;41(1):73-83
references: 10942644
references: Med Mal Infect. 2005 Jun;35 Suppl 2:S125-6
references: 15978368
references: Cochrane Database Syst Rev. 2014 Feb 11;(2):CD000243
references: 24515610
references: Scand J Infect Dis. 2011 Jul;43(6-7):479-88
references: 21299365
references: Int J Infect Dis. 2006 Jan;10(1):61-5
references: 16298536
references: Eur J Clin Pharmacol. 2006 May;62(5):373-9
references: 16568344
references: Indian J Pediatr. 2008 Aug;75(8):815-20
references: 18769893
references: Salud Publica Mex. 2003 May-Jun;45(3):159-64
references: 12870416
references: Cochrane Database Syst Rev. 2013 Apr 30;(4):CD004406
references: 23633318
references: Am Fam Physician. 2001 Sep 15;64(6):999-1004
references: 11578036
references: Fam Pract. 2010 Dec;27(6):684-90
references: 20660529
references: Int J Antimicrob Agents. 2005 Aug;26(2):106-13
references: 16009535
references: CMAJ. 2008 Mar 25;178(7):845-54
references: 18362380
references: J Antimicrob Chemother. 2002 Jun;49(6):897-903
references: 12039881
references: Int J Infect Dis. 2010 Jan;14(1):e55-61
references: 19487149
references: Ital J Pediatr. 2011 Jan 31;37:10
references: 21281502
references: Eur J Clin Pharmacol. 2007 Dec;63(12):1099-106
references: 17891535
references: J Chemother. 2002 Apr;14(2):181-4
references: 12017374
references: Fam Pract. 1996 Oct;13(5):445-9
references: 8902513